Clinical prognostic impact of C-NLR in heart failure patients with different ejection fractions: a retrospective study

BMC Cardiovasc Disord. 2024 Jan 17;24(1):54. doi: 10.1186/s12872-024-03714-4.

Abstract

Objection: Inflammatory conditions and immune disorders may worsen the prognosis of chronic heart failure (CHF) patients. The aim of this study was to evaluate the prognostic value of a new indicator, C-NLR, composed of C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), for the risk of all-cause mortality in HF patients with different ejection fractions.

Methods: A total of 1221 CHF patients admitted to the First Affiliated Hospital of Kunming Medical University from January 2017 to October 2021 were enrolled in this study. All patients were divided into 2 groups according to the median C-NLR. Kaplan-Meier survival curves were used to compare the all-cause mortality among CHF patients with different ejection fractions. Cox proportional hazards analysis was used to evaluate the relationships between variables and mortality. The predictive value of the C-NLR was assessed by using receiver operating characteristic (ROC) analyses.

Results: We collected data from 1192 patients with CHF. Kaplan-Meier survival analysis revealed that patients with low LCR levels had better overall survival (OS). After multivariate adjustment Cox proportional hazards analysis, the level of C-NLR was still independently related to mortality.

Conclusions: C-NLR was a competent independent predictor in HF with different ejection fractions, and routine measurement of C-NLR would help clinical doctors identify patients with a poor prognosis.

Keywords: Ejection fraction; Heart failure; Immunity; Inflammation; Prognosis.

MeSH terms

  • Heart Failure* / diagnosis
  • Heart Failure* / metabolism
  • Humans
  • Lymphocytes / metabolism
  • Neutrophils* / metabolism
  • Prognosis
  • Retrospective Studies